Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Focus on Europe

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 19 July 1996:
Vol. 273. no. 5273, pp. 305 - 306
DOI: 10.1126/science.273.5273.305b
Prev | Table of Contents | Next

News & Comment

Jocelyn Kaiser

A panel put together by the Institute of Medicine (IOM) concludes in a report released this week that the benefits of xenotransplants outweigh the risks that the procedure might permit animal pathogens to cross the species barrier into humans. The panel advises, however, that new trials should be delayed until the government has put some guidelines into place. The U.S. Department of Health and Human Services is now finalizing rules that mirror those suggested by the IOM panel, and experiments, which have been on hold for several months, may soon be resumed.




ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)